X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/18/2865312/0/en/Windtree-Therapeutics-Announces-Reverse-Stock-Split.html
https://www.globenewswire.com/news-release/2024/04/17/2864452/0/en/Windtree-Therapeutics-Reports-Fourth-Quarter-and-Year-End-2023-Financial-Results-and-Provides-Key-Business-Updates.html
https://www.globenewswire.com/news-release/2024/04/08/2859612/0/en/Windtree-Acquires-Early-Stage-Novel-Oncology-Platform-and-Completes-1-5-Million-Convertible-Note-Bridge-Financing.html
https://www.globenewswire.com//news-release/2024/02/01/2821921/0/en/Windtree-Renews-Agreement-with-Chang-Gung-University-for-Scientific-Collaboration-to-Further-SERCA2a-Research.html
https://www.globenewswire.com/news-release/2024/01/31/2821047/0/en/Windtree-Therapeutics-Announces-Engagement-of-Strategic-Advisor-to-Support-Assessment-of-Strategic-Alternatives.html
https://www.globenewswire.com//news-release/2024/01/25/2816759/0/en/Windtree-Eliminates-15-Million-Contingent-Liability-to-Deerfield-Management-Company.html
https://www.fiercebiotech.com/biotech/windtree-blows-toward-lees-pharma-once-again-signing-new-deal
https://www.globenewswire.com//news-release/2024/01/17/2810651/0/en/Windtree-Therapeutics-Announces-License-Agreement-with-Lee-s-Pharmaceuticals-to-Develop-and-Commercialize-Istaroxime-Dual-Mechanism-SERCA2a-Activators-and-Rostafuroxin-for-Greater-.html
https://www.globenewswire.com//news-release/2024/01/02/2802918/0/en/Windtree-Therapeutics-Announces-Reduction-In-Arrythmias-In-A-New-Study-With-Istaroxime-And-A-Pure-SERCA2a-Activator.html
https://www.globenewswire.com//news-release/2023/12/18/2797777/0/en/Windtree-Therapeutics-Announces-the-Start-of-Patient-Dosing-In-Phase-2-SEISMiC-Extension-Study-of-Istaroxime-in-Early-Cardiogenic-Shock.html
Market Place
Share 
